PODCAST: The first episode of a new series from The Anthill focuses on precision medicine.
Academic rigor, journalistic flair
Articles on Precision medicine series
Displaying all articles
“Precision medicine” is allowing us to analyse a person’s genetic makeup and target treatments based on their specific needs.
It’s exciting to think we’re on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn’t mean it should automatically be publicly funded.
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
Top contributors
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Executive Director, Garvan Institute of Medical Research, Garvan Institute
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor, Central Clinical School, Monash University
-
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Head of Medical Genomics- Glasgow Precision Oncology Laboratory , University of Glasgow
-
Regius Professor of Medicine, Vice Principal and Head of College of Medical, Veterinary and Life Sciences, University of Glasgow
-
Professor and Regius Chair of Surgery, Director of Translational Research Centre, University of Glasgow
-
Professor of Medicine, University of Oxford
-
Muirhead Chair of Medicine and Director of Institute of Infection, Immunity and Inflammation, University of Glasgow
